BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Cell & Gene

Elpis Biopharmaceuticals and Singapore General Hospital Partner to Advance Next-Gen CAR-γδT Cell Therapies for AML and Multiple Myeloma

Elpis Biopharmaceuticals, a clinical-stage cell therapy company developing bispecific armored CAR-T therapies for solid tumors, today announced entry into ...

June 05, 2025 | News

JW Therapeutics Secures Macao Approval for CAR-T Therapy Carteyva®, Marking First Overseas Market Entry

JW Therapeutics (HKEx: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunother...

June 05, 2025 | News

XellSmart Advances Global Leadership in iPSC-Derived Cell Therapies for CNS Disorders

XellSmart Biomedical Co., Ltd. (Suzhou/Shanghai, China) is a leading biotechnology company dedicated to the development of innovative iPSC-derived cell the...

June 03, 2025 | News

AccurEdit’s ART001 Becomes First China-Developed Gene Editing Therapy to Receive FDA RMAT Designation

AccurEdit Therapeutics announced that its internally developed in vivo gene editing therapy ART001 has been granted a Regenerative Medi...

May 30, 2025 | News

CorestemChemon's Neuronata-R® Shows Promising Efficacy in Early-Stage ALS, Sets Sights on Accelerated FDA Approval

Neuronata-R®, an autologous bone marrow-derived mesenchymal stem cell (MSC) therapy for amyotrophic lateral sclerosis (ALS), has demonstrated meaningfu...

May 30, 2025 | News

Gene Weaver Secures Gates Foundation Grant to Advance Next-Gen Gene Insertion Platform for Affordable Therapeutics

Gene Weaver Ltd (Gene Weaver), a biology technology innovator, has received $515,214 from the Gates Foundation to support the development of a n...

May 29, 2025 | News

UniXell Biotech Initiates China’s First iPSC-Based Cell Therapy Trial for Parkinson’s Disease

Shanghai UniXell Biotechnology Co., Ltd. (UniXell Biotech), a biotech company dedicated to innovative cell therapies, announced the successful first admini...

May 26, 2025 | News

Porton Advanced and TongEYE Partner to Accelerate iPSC-Derived Cell Therapy for Blinding Eye Diseases

Porton Advanced, a leading contract development and manufacturing organization (CDMO) specializing in advanced therapy medicinal products (ATMPs), is pleas...

May 23, 2025 | News

KFSHRC and Cellenkos Join Forces to Launch First Saudi-U.S. Clinical Trials for Treg Cell Therapies

KFSHRC to lead Clinical Trials Targeting Aplastic Anemia and Graft vs. Host Disease Cellenkos to Support Local Cell and Gene Therapy Manufacturing at&nb...

May 23, 2025 | News

Waters Corporation Acquires Halo Labs to Advance Analytical Capabilities for Cell and Gene Therapy Development

Waters Corporation announced that it has acquired Halo Labs™, an innovator of specialized imaging technologies to detect, identify, and count i...

May 22, 2025 | News

AGC Biologics Partners with Quell Therapeutics to Advance Treg Cell Therapies for Immune Disorders

-AGC Biologics, your friendly CDMO expert, announced a partnership with Quell Therapeutics (“Quell”), a clinical-stage bio...

May 19, 2025 | News

Thermo Fisher Scientific Opens Cell and Gene Therapy Vision Center in South Korea

— Thermo Fisher Scientific, the world leader in serving science, has announced the official opening of its new Cell and Gene Therapy (CGT) Vision Cen...

May 15, 2025 | News

IASO Bio’s BCMA CAR-T Therapy Equecabtagene Autoleucel Granted Orphan Drug Designation in Saudi Arabia

IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovat...

May 12, 2025 | News

Altaris Unites WuXi and Minaris Assets to Launch Minaris Advanced Therapies as Global Cell Therapy CDMO Powerhouse

Through strategic acquisitions made by New York–based investment firm Altaris, Minaris Regenerative Medicine and the U.S. and U.K. operations of WuXi...

May 08, 2025 | News

Stay Connected